Navigation Links
WebPAX v8 - The fastest, most technologically advanced zero-footprint medical image viewer yet
Date:7/16/2013

DURHAM, N.C., July 16, 2013 /PRNewswire/ -- Heart IT, the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, announced today the release of Version 8 of their flagship products: WebPAX® PACS and Universal Viewer.

The WebPAX® product line offers leading edge medical image management and distribution platforms that enable the viewing of all medical images, including Radiology and Cardiology images, on the web, on a zero-footprint basis, and 100% diagnostic quality. The newest release of WebPAX® offers a number of key features and enhancements, which are all designed to improve the workflow of the Cardiologist and Radiologist reading medical images. Version 8 offers an array of improvements in admin tools, viewer tools, image management, as well as patient management. One of the primary benefits of WebPAX® version 8 is that it increases the speed by which medical images can be viewed on the web independently of the available bandwidth.

Michael Parsons, Director of Software Development, said "WebPAX® version 8 is our most effective and comprehensive release yet. As a web-based medical imaging viewing application, one of the greatest challenges we face, is facilitating the viewing of medical images over the bandwidth that is available to the customer, regardless of location. In Version 8, through the utilization of HTML 5 technologies and increasing the efficiency of our code, we have been able to significantly improve the speed by which the medical images can be loaded and displayed."

Brent Reed, CTO stated: "It's now commonplace for physicians to make their primary reads outside of the physical walls of the hospital. Version 8 leverages brand new technology which optimizes that experience. For example, Cardiologists who read Echo's at home will now be able to navigate all series of a study in quick succession comparable to how they view them through standalone workstations. V8 changes the way images can be accessed by physicians and truly has the potential to improve the quality of care for patients."

About Heart IT:
Founded in 2000 and headquartered near North Carolina's Research Triangle Park, Heart IT is a global leader in the medical image web enablement field. Their flagship product, WebPAX® is the first FDA approved zero-footprint medical image workstation. It provides web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, WebPAX® systems currently provide secure web browser access to over one billion medical images. For more information visit our website at www.heartit.com.

LOGO: http://send2press.com/mediaboom/13-0715-webpax_72dpi.jpg

This release was issued through Send2Press(R), a unit of Neotrope(R). For more information, visit Send2Press Press Release Distribution at http://www.Send2Press.com


'/>"/>
SOURCE Heart IT
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New RCSA Certification Curriculum Uses Angio Mentor Simulators for Advanced Training
2. JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems
3. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
4. Belrose Pharma Acquires Enzons Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies
5. New drug proving effective in attacking advanced prostate cancer
6. Ochsner Health System Improves Safety Through Advanced Medication Management Technology
7. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
8. New Air Products Microsite Features Advanced Liquid Nitrogen Solutions for the Chemical, Pharmaceutical, and Life Science Industries
9. Merrimack Pharmaceuticals Phase 1 Research Supports MM-121 Potential For Investigation As Combination With Chemotherapy In Patients With Advanced Solid Tumors
10. New Prefillable Syringe System Offers Advanced Glass Technology for Biopharmaceutical Injectable Drug Delivery
11. Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 30, 2017 Revenue Prospects by Product Type ... COPD) and Geography Respiratory Inhalers - our new study ... Respiratory Inhalers market heading? If you are involved in this sector ... shows you the potential revenues streams to 2027, assessing data, trends, ... ...
(Date:3/29/2017)... , March 29, 2017 Wound care devices ... healing of the wound. The industry mainly consists of ... for the treatment of wounds caused by mechanical, chemical, ... to diseases such as diabetes, skin related diseases, immunological ... Europe was the largest region in the ...
(Date:3/29/2017)... , March 29, 2017  BioSpecifics Technologies Corp. ... continues to develop collagenase based-therapies with a first ... marketed as XIAFLEX ®  in the U.S. and ... present a corporate overview at the upcoming 16 ... April 5, 2017 at 8:00 a.m. ET in ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... March 30, 2017 , ... ... Academy of Nutrition and Dietetics (AND), will join nonprofit Seafood Nutrition Partnership (SNP) ... a live webinar designed to help nutrition educators and students inform consumers about ...
(Date:3/29/2017)... ... ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today that Rhino Ag has ... of more than 650 U.S.-based dealers. Rhino, a member of the Alamo Group, offers ... and cutters, rear blades, post hole diggers, pasture renovators, tillers, disc mowers and box ...
(Date:3/29/2017)... ... ... is the main cause of hay fever in the United States, with an estimated 95 ... May to July each year; with the worst time for sufferers being June and July. ... http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent studies ...
(Date:3/29/2017)... ... 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale ... for the remaining days of March, the price will be only $19.97. The EXOUS ... of just $10 (regular retail price $19.97). , The special promotional prices are to ...
(Date:3/29/2017)... ... 29, 2017 , ... Based on research from Guardian’s Fourth ... in trying to balance both short-term and long-term benefits demands. Are employers ... growing complexity, companies are finding that the short-term strategies used to control costs, ...
Breaking Medicine News(10 mins):